Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Gains from Investment Securities (2016 - 2025)

Ekso Bionics Holdings has reported Gains from Investment Securities over the past 7 years, most recently at $115000.0 for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $115000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $115000.0, a N/A change, with the full-year FY2021 number at -$134000.0, down 139.29% from a year prior.
  • Gains from Investment Securities reached $115000.0 in Q3 2025 per EKSO's latest filing, up from $78000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $873000.0 in Q3 2023, with the low at -$131000.0 in Q4 2021.
  • The 3-year median for Gains from Investment Securities is $96500.0 (2025), against an average of $233750.0.
  • The largest YoY upside for Gains from Investment Securities was 13000.0% in 2021 against a maximum downside of 13000.0% in 2021.
  • Tracing EKSO's Gains from Investment Securities over 3 years: stood at -$131000.0 in 2021, then skyrocketed by 766.41% to $873000.0 in 2023, then tumbled by 86.83% to $115000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $115000.0, $78000.0, and $873000.0 for Q3 2025, Q2 2025, and Q3 2023 respectively.